Z A Brown1, S Schalekamp-Timmermans2, H W Tiemeier3, A Hofman4, V W V Jaddoe5, E A P Steegers6. 1. The Generation R Study Group, Erasmus Medical Centre, Rotterdam, The Netherlands; Department of Obstetrics and Gynecology, Erasmus Medical Centre, Rotterdam, The Netherlands. Electronic address: z.brown@erasmusmc.nl. 2. The Generation R Study Group, Erasmus Medical Centre, Rotterdam, The Netherlands; Department of Obstetrics and Gynecology, Erasmus Medical Centre, Rotterdam, The Netherlands. 3. Department of Epidemiology, Erasmus Medical Centre, Rotterdam, The Netherlands; Department of Psychiatry, Erasmus Medical Centre, Rotterdam, The Netherlands. 4. Department of Epidemiology, Erasmus Medical Centre, Rotterdam, The Netherlands. 5. The Generation R Study Group, Erasmus Medical Centre, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus Medical Centre, Rotterdam, The Netherlands. 6. Department of Obstetrics and Gynecology, Erasmus Medical Centre, Rotterdam, The Netherlands.
Abstract
INTRODUCTION: Our objective was to assess fetal sex specific differences in first trimester placental biomarkers of both physiological and pathological pregnancies and their interaction with environmental influences. This study is embedded in the Generation R Study, a prospective cohort study. METHODS: Only live singleton births were included. Linear regression was performed to assess the effect of sex on first trimester placental biomarkers. Interaction analyses were performed to assess interaction of fetal sex with environmental influences. First trimester soluble fms-like tyrosine kinase (s-Flt1), placental growth factor (PLGF), plasminogen activator inhibitor (PAI-2) and homocysteine levels were assessed. RESULTS: Significant fetal sex specific differences in placental biomarkers were observed. S-Flt1, PAI-2 and PLGF log transformated concentrations were 0.08 ng/mL (95% CI 0.05; 0.11), 0.07 ng/mL (95% CI 0.06; 0.09) and 0.04 pg/mL (95% CI 0.01; 0.06) higher in case of female as compared to male placentas. In pregnancies complicated by pre-eclampsia (PE), preterm birth (PTB) or a newborn being small for gestational age (SGA) no fetal sex specific differences were observed. Interaction analyses suggest that concentrations of s-Flt1, PLGF and PAI-2 decrease in male placentas in the case of hyperhomocysteinemia but remain equal in female placentas. DISCUSSION: Fetal sex affects early placentation processes with discrepancies regarding pregnancies complicated by PE, PTB or a newborn being SGA. This suggests that other mechanisms causing these complications may dominate the fetal sex effect. The differences concerning homocysteine suggest that fetal sex dependent placental gene-environment interactions exist. CONCLUSION: Fetal sex specific differences in placental biomarkers exist.
INTRODUCTION: Our objective was to assess fetal sex specific differences in first trimester placental biomarkers of both physiological and pathological pregnancies and their interaction with environmental influences. This study is embedded in the Generation R Study, a prospective cohort study. METHODS: Only live singleton births were included. Linear regression was performed to assess the effect of sex on first trimester placental biomarkers. Interaction analyses were performed to assess interaction of fetal sex with environmental influences. First trimester soluble fms-like tyrosine kinase (s-Flt1), placental growth factor (PLGF), plasminogen activator inhibitor (PAI-2) and homocysteine levels were assessed. RESULTS: Significant fetal sex specific differences in placental biomarkers were observed. S-Flt1, PAI-2 and PLGF log transformated concentrations were 0.08 ng/mL (95% CI 0.05; 0.11), 0.07 ng/mL (95% CI 0.06; 0.09) and 0.04 pg/mL (95% CI 0.01; 0.06) higher in case of female as compared to male placentas. In pregnancies complicated by pre-eclampsia (PE), preterm birth (PTB) or a newborn being small for gestational age (SGA) no fetal sex specific differences were observed. Interaction analyses suggest that concentrations of s-Flt1, PLGF and PAI-2 decrease in male placentas in the case of hyperhomocysteinemia but remain equal in female placentas. DISCUSSION: Fetal sex affects early placentation processes with discrepancies regarding pregnancies complicated by PE, PTB or a newborn being SGA. This suggests that other mechanisms causing these complications may dominate the fetal sex effect. The differences concerning homocysteine suggest that fetal sex dependent placental gene-environment interactions exist. CONCLUSION: Fetal sex specific differences in placental biomarkers exist.
Authors: Claudia J Kruithof; Marjolein N Kooijman; Cornelia M van Duijn; Oscar H Franco; Johan C de Jongste; Caroline C W Klaver; Johan P Mackenbach; Henriëtte A Moll; Hein Raat; Edmond H H M Rings; Fernando Rivadeneira; Eric A P Steegers; Henning Tiemeier; Andre G Uitterlinden; Frank C Verhulst; Eppo B Wolvius; Albert Hofman; Vincent W V Jaddoe Journal: Eur J Epidemiol Date: 2014-12-21 Impact factor: 8.082
Authors: Karen J Gibbins; Katherine N Gibson-Corley; Ashley S Brown; Matthew Wieben; Richard C Law; Camille M Fung Journal: Biol Reprod Date: 2018-05-01 Impact factor: 4.285
Authors: Rojan Saghian; Lindsay Cahill; Anum Rahman; Joseph Steinman; Greg Stortz; John Kingdom; Christopher Macgowan; John Sled Journal: IEEE Trans Biomed Eng Date: 2021-11-23 Impact factor: 4.538
Authors: Pandora L Wander; Colleen M Sitlani; Sylvia E Badon; David S Siscovick; Michelle A Williams; Daniel A Enquobahrie Journal: Matern Child Health J Date: 2015-11
Authors: Amy E Braun; Kristin L Muench; Beatriz G Robinson; Angela Wang; Theo D Palmer; Virginia D Winn Journal: Reprod Sci Date: 2020-11-04 Impact factor: 3.060
Authors: Ashley S Meakin; James S M Cuffe; Jack R T Darby; Janna L Morrison; Vicki L Clifton Journal: Int J Mol Sci Date: 2021-06-15 Impact factor: 5.923